Chade Alejandro R, Rodriguez-Porcel Martin, Herrmann Joerg, Krier James D, Zhu Xiangyang, Lerman Amir, Lerman Lilach O
Division of Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA.
Hypertension. 2003 Oct;42(4):605-12. doi: 10.1161/01.HYP.0000089880.32275.7C. Epub 2003 Aug 18.
Renal artery stenosis (RAS) may lead to renal injury, partly mediated through increased oxidative stress. However, the potential effects of chronic oral antioxidant intervention on the stenotic kidney remain unknown. This study was designed to test the hypothesis that chronic antioxidant vitamin supplementation in RAS would preserve renal function and structure. Single-kidney hemodynamics and function were quantified in vivo in pigs using electron-beam CT after 12 weeks of unilateral RAS (n=7), a similar degree of RAS orally supplemented with vitamins C (1 g) and E (100 IU/kg) (RAS+Vitamins, n=7), or controls (normal, n=7). Renal tissue was studied ex vivo using Western blotting and immunohistochemistry. Mean arterial pressure was similarly elevated in both RAS groups, while ischemic renal volume and glomerular filtration rate were similarly reduced. Renal blood flow was decreased in RAS compared with normal (326.5+/-99.9 versus 553.4+/-48.7 mL/min, respectively, P=0.01), but preserved in RAS+Vitamins (485.2+/-104.1 mL/min, P=0.3 versus normal). The marked increase in the expression of the NADPH-oxidase subunits p47phox and p67phox, nitrotyrosine, endothelial and inducible nitric oxide synthase, and nuclear factor-kappaB observed in RAS (P<0.05 versus normal) was normalized in RAS+Vitamins (P>0.1). Furthermore, trichrome staining and the expression of transforming growth factor-beta and tissue inhibitor of matrix-metalloproteinase-1 were also decreased in RAS+Vitamins. In conclusion, chronic blockade of the oxidative stress pathway in RAS using antioxidant vitamins improved renal hemodynamics and decreased oxidative stress, inflammation, and fibrosis in the ischemic kidney. These observations underscore the involvement of oxidative stress in renal injury in RAS and support a role for antioxidant vitamins in preserving the ischemic kidney.
肾动脉狭窄(RAS)可能导致肾损伤,部分是通过增加氧化应激介导的。然而,慢性口服抗氧化剂干预对狭窄肾脏的潜在影响尚不清楚。本研究旨在检验以下假设:在RAS中慢性补充抗氧化维生素可保护肾功能和结构。在单侧RAS(n = 7)、口服补充维生素C(1 g)和维生素E(100 IU/kg)的相似程度RAS(RAS + 维生素,n = 7)或对照组(正常,n = 7)12周后,使用电子束CT在猪体内对单肾血流动力学和功能进行定量。使用蛋白质印迹法和免疫组织化学对肾组织进行离体研究。两个RAS组的平均动脉压均同样升高,而缺血肾体积和肾小球滤过率均同样降低。与正常组相比,RAS组肾血流量减少(分别为326.5±99.9与553.4±48.7 mL/min,P = 0.01),但在RAS + 维生素组中得以保留(485.2±104.1 mL/min,与正常组相比P = 0.3)。在RAS组中观察到的NADPH氧化酶亚基p47phox和p67phox、硝基酪氨酸、内皮型和诱导型一氧化氮合酶以及核因子κB的表达显著增加(与正常组相比P < 0.05),在RAS + 维生素组中恢复正常(P > 0.1)。此外,RAS + 维生素组中三色染色以及转化生长因子β和基质金属蛋白酶组织抑制剂-1的表达也降低。总之,使用抗氧化维生素对RAS中的氧化应激途径进行慢性阻断可改善肾血流动力学,并降低缺血肾脏中的氧化应激、炎症和纤维化。这些观察结果强调了氧化应激在RAS肾损伤中的作用,并支持抗氧化维生素在保护缺血肾脏中的作用。